abstract |
The invention describes monocyclic aryl compounds having selective properties of LTB4 antagonists and comprising an amido substituent, a substituent group having an end-chain carboxylic acid or a derivative thereof, as well as a lipophilic substituent; the invention also describes therapeutic compositions and methods for treating diseases originating from LTB4 activity, using said monocyclic aryl compounds. |